Table 2.
Primer sequences used in this study
| Gene | Direction | Sequence (5'→3') | Product size (bp) | GenBank accession |
| DGAT1 | Forward Reverse | AGGACGGACACGACGAT GAACGCAGTCACAGCAAA | 287 | NM_214051.1 |
| DGAT2 | Forward Reverse | TCCTGTCTTTCCTCGTGC ACCTTTCTTGGGCGTGT | 131 | NM_001160080.1 |
| HNF-4α | Forward Reverse | ATCGCCACCATCGTCAA CCTCACCCTTTCCACTACCA | 200 | NM_001044571.1 |
| SREBP-1c | Forward Reverse | AAGCGGACGGCTCACAA GCAAGACGGCGGATTTATT | 121 | NM_214157.1 |
| FASN1 | Forward Reverse | CCTGGGAAGAGTGTAAGCA GGAACTCGGACATAGCG | 108 | NM_001099930.1 |
| PPAR-γ | Forward Reverse | AAGACGGGGTCCTCATCTCC CGCCAGGTCGCTGTCATCT | 149 | NM_214379.1 |
| PPAR-a | Forward Reverse | TCAAGAGCCTGAGGAAACCC CAAATGATAGCAGCCACAAAGAG | 153 | NM_001044526.1 |
| β-actin | Forward Reverse | CATCGTCCACCGCAAAT TGTCACCTTCACCGTTCC | 210 | NC_010445 |
| FABP4 | Forward Reverse | GTTACGGCTTCTTTCTC ATGGTGCTCTTGACTTT | 293 | NM_001002817.1 |
| Insig-1 | Forward Reverse | GGACTCCTGGACAAAACG GATTCGGGATTCTGGATAAA | 191 | NM_001244521.1 |
| Insig-2 | Forward Reverse | CTTTGGTTCAGACAGTTGG CTACGCACCGCATTACA | 225 | NM_001129968.1 |
| HMGCR | Forward Reverse | ACAGGATGAAGTAAGGGAGA CGAAGTAGGTGGCGAGA | 234 | NM_001122988.1 |
| CPT1 | Forward Reverse | GAAACGGAGCAAGGGTA GTGGTGAACGGAAAGGA | 182 | NM_001007191.1 |
| CPT2 | Forward Reverse | CACTTGTTTGCTTTGCG GCTGGTGGACAGGATGTT | 130 | NM_001246243.1 |
| CES1 | Forward Reverse | AGCAGGAGGGGAAAGTG CAGGCAGTGAACAAAGACA | 193 | NM_214246.2 |
| CES3 | Forward Reverse | GGGACTCCTGCTTTCTGT TGGGCTATGCTGTAATGG | 172 | NM_001243625.1 |
| COMT | Forward Reverse | CTCGCAGATGGTGGATG AGTTGGCAGAAGTGGGTT | 138 | NM_001195330 |
| SC4MOL | Forward Reverse | GGAAAACCAGTGGAAATG TGCCAGGTATCCTCAATC | 186 | NM_213752.1 |
| CCL2 | Forward Reverse | GAAGAGTCACCAGCAGCAAG TGAGGGTATTTAGGGCAAGTT | 215 | NM_214214.1 |
| CXCL12 | Forward Reverse | TGCCCTTGCCGATTCTT GAGTGGGACTGGGTTTGTTT | 193 | NM_001009580 |
DGAT1, diacylglycerol O-acyltransferase 1; DGAT2, diacylglycerol O-acyltransferase 2; HNF-4α, hepatocyte nuclear factor-4α; SREBP-1c, sterol regulatory element binding protein 1c; FASN1, fatty acid synthase 1; PPAR-γ, proliferator-activated receptor-γ; PPAR-α, proliferator-activated receptor α; FABP4, fatty acid binding protein 4; HMGCR, HMG-CoA reductase; CPT1, carnitine palmitoyl transferase 1; CPT2, carnitine palmitoyl transferase 2; CES1, carboxylesterase 1; CES3, carboxylesterase 3; COMT, catechol-O-methyltransferase; SC4MOL, sterol-C4-methyl oxidase-like; CCL2, chemokine (C–C motif) ligand 2; CXCL12, chemokine (C–X–C motif) ligand 12